Request Demo
Last update 07 Mar 2025
Kira Pharmaceuticals (Suzhou) Co., Ltd.
Holding Company | Subsidiary Company|
2017|
Jiangsu Sheng, China
Last update 07 Mar 2025
Overview
Basic Info
Introduction Kira Pharmaceuticals is a Chinese corporation headquartered in Suzhou and has branches in the United States. Their primary business involves the production and distribution of antibody drugs. |
Tags
Urogenital Diseases
Other Diseases
Immune System Diseases
Antibody fusion proteins
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20222784
一项评价KP104在未接受过补体抑制剂治疗的阵发性睡眠性血红蛋白尿症（PNH）受试者中的安全性、耐受性、药代动力学、药效学和有效性的开放性II期研究
[Translation] An open-label Phase II study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of KP104 in subjects with paroxysmal nocturnal hemoglobinuria (PNH) who have not received complement inhibitor therapy
CTR20223383
一项评价KP104在IgA肾病（IgAN）和C3肾小球病（C3G）受试者中的有效性、安全性、药代动力学和药效学的开放性II期研究
[Translation] An open-label Phase II study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of KP104 in subjects with IgA nephropathy (IgAN) and C3 glomerulopathy (C3G)
100 Clinical Results associated with Kira Pharmaceuticals (Suzhou) Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Kira Pharmaceuticals (Suzhou) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Kira Pharmaceuticals (Suzhou) Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 04 Apr 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free